Publications

Publications from our lab members.
Selected publications from our lab members
  1. Frederiksen, L. E., Erdmann, F., Mader, L., Mogensen, H., Pedersen, C., Kenborg, L., Bautz, A., Talbäck, M., Hirvonen, E., Nielsen, T. T., Andersen, E. A. W., Holmqvist, A. S., Jørgensen, O. S., Jepsen, J. R. M., Malila, N., Hasle, H., Madanat-Harjuoja, L., Feychting, M., & Winther, J. F. (2022). Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: A register-based cohort study from the SALiCCS research programme. The Lancet Psychiatry. 
  2. Kitahara, C. M., Daltveit, D. S., Ekbom, A., Engeland, A., Gissler, M., Glimelius, I., Grotmol, T., Lagerros, Y. T., Madanat-Harjuoja, L., Männistö, T., Sørensen, H. T., Troisi, R., & Bjørge, T. (2021). Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: A Nordic population-based nested case-control study. The Lancet Diabetes & Endocrinology.
  3. Madanat-Harjuoja, L. M., Klega, K., Lu, Y., Shulman, D. S., Thorner, A. R., Nag, A., Tap, W. D., Reinke, D. K., Diller, L., Ballman, K. V., George, S., & Crompton, B. D. (2022). Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. Clinical Cancer Research.
  4. Madanat-Harjuoja, L. M., Renfro, L. A., Klega, K., Tornwall, B., Thorner, A. R., Nag, A., Dix, D., Dome, J. S., Diller, L. R., Fernandez, C. V., Mullen, E. A., & Crompton, B. D. (2022). Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children’s Oncology Group Trial, AREN0533. Journal of Clinical Oncology.
  5. Madanat-Harjuoja, L.-M., Pitkäniemi, J., Hirvonen, E., Malila, N., & Diller, L. R. (2020). Linking population-based registries to identify familial cancer risk in childhood cancer. Cancer.
  6. Sørensen, G. V., Winther, J. F., de Fine Licht, S., Andersen, K. K., Holmqvist, A. S., Madanat-Harjuoja, L., Tryggvadottir, L., Bautz, A., Lash, T. L., Hasle, H., & On behalf of the ALiCCS study group. (2019). Long-Term Risk of Hospitalization Among Five-Year Survivors of Childhood Leukemia in the Nordic Countries. JNCI: Journal of the National Cancer Institute. 
  7. Pourjamal, N., Yazdi, N., Halme, A., Joncour, V. L., Laakkonen, P., Saharinen, P., Joensuu, H., & Barok, M. (2024). Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model. Clinical & Experimental Metastasis.